september 29, 2015
CERAMENTT with Gentamicin Shown to Decrease Recurrence of Infection and Increase Bone FormationLund, Sweden, (PRNEWSWIRE) September 24, 2015 - BONESUPPORTT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, today announced the presentation of new clinical data with the Company's platform bone void filler, CERAMENTT...
During its first year of operations, Vtesse advances lead program into late-stage, pivotal trial and launches www.theNPCstudy.com- Goal is to establish a clear foundational data set on the safety and efficacy of VTS-270 for treatment of NPCGAITHERSBURG, Md., Sept. 28, 2015 /PRNewswire/ -- Vtesse, Inc. today announced that the first three patients have been screened for inclusion in...


Lundbeckfonden øger sit engagement i IO Biotech
12. januar 2021
Lundbeckfonden lancerer 2030-strategi med ambitiøse mål for både uddelings- og erhvervsaktiviteterne
22. december 2020
Lundbeckfonden uddeler 57 mio. kr. til dristige projekter
15. december 2020


Lundbeckfonden Ventures

Lundbeckfonden Emerge